• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变异株感染的知晓情况在近期新冠血清阳性的成年人中。

Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.

机构信息

Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

David Geffen School of Medicine, UCLA (University of California, Los Angeles).

出版信息

JAMA Netw Open. 2022 Aug 1;5(8):e2227241. doi: 10.1001/jamanetworkopen.2022.27241.

DOI:10.1001/jamanetworkopen.2022.27241
PMID:35976645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9386542/
Abstract

IMPORTANCE

Some individuals who were infected by the SARS-CoV-2 Omicron variant may have been completely unaware of their infectious status while the virus was actively transmissible.

OBJECTIVE

To examine awareness of infectious status among individuals during the recent Omicron variant surge in a diverse and populous urban region of Los Angeles County.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study analyzed the records of adult employees and patients of an academic medical center who were enrolled in a longitudinal COVID-19 serological study in Los Angeles County, California. These participants had 2 or more serial anti-nucleocapsid IgG (IgG-N) antibody measurements at least 1 month apart, with the first occurring after the end of a regional Delta variant surge (September 15, 2021) and a subsequent one occurring after the start of a regional Omicron variant surge (December 15, 2021). Adults with evidence of new SARS-CoV-2 infection occurring during the Omicron variant surge period through May 4, 2022, were included in the present study sample.

EXPOSURES

Recent Omicron variant infection as evidenced by SARS-CoV-2 seroconversion.

MAIN OUTCOMES AND MEASURES

Awareness of recent SARS-CoV-2 infection was ascertained from review of self-reported health updates, medical records, and COVID-19 testing data.

RESULTS

Of the 210 participants (median [range] age, 51 (23-84) years; 136 women [65%]) with serological evidence of recent Omicron variant infection, 44% (92) demonstrated awareness of any recent Omicron variant infection and 56% (118) reported being unaware of their infectious status. Among those who were unaware, 10% (12 of 118) reported having had any symptoms, which they attributed to a common cold or other non-SARS-CoV-2 infection. In multivariable analyses that accounted for demographic and clinical characteristics, participants who were health care employees of the medical center were more likely than nonemployees to be aware of their recent Omicron variant infection (adjusted odds ratio, 2.46; 95% CI, 1.30-4.65).

CONCLUSIONS AND RELEVANCE

Results of this study suggest that more than half of adults with recent Omicron variant infection were unaware of their infectious status and that awareness was higher among health care employees than nonemployees, yet still low overall. Unawareness may be a highly prevalent factor associated with rapid person-to-person transmission within communities.

摘要

重要性

在洛杉矶县的一个多样化和人口众多的城市地区,最近的奥密克戎变体激增期间,一些感染了 SARS-CoV-2 奥密克戎变体的个体在病毒具有高度传染性时可能完全没有意识到自己的感染状态。

目的

在加利福尼亚州洛杉矶县的一个学术医疗中心,对参与一项关于 COVID-19 血清学的纵向研究的成年员工和患者的记录进行分析,以调查在最近的奥密克戎变体激增期间个体对感染状态的认知。

设计、地点和参与者:本队列研究分析了在加利福尼亚州洛杉矶县参与一项关于 COVID-19 血清学的纵向研究的成年员工和患者的记录。这些参与者至少相隔 1 个月接受了 2 次或更多次连续的抗核衣壳 IgG(IgG-N)抗体测量,第一次发生在地区性德尔塔变体激增结束后(2021 年 9 月 15 日),随后一次发生在地区性奥密克戎变体激增开始后(2021 年 12 月 15 日)。本研究样本纳入了在 2022 年 5 月 4 日之前的奥密克戎变体激增期间有新的 SARS-CoV-2 感染证据的成年人。

暴露

奥密克戎变体感染的近期证据为 SARS-CoV-2 血清转换。

主要结果和措施

通过审查自我报告的健康更新、医疗记录和 COVID-19 检测数据来确定对近期 SARS-CoV-2 感染的认识。

结果

在 210 名具有最近奥密克戎变体感染血清学证据的参与者(中位数[范围]年龄,51[23-84]岁;136 名女性[65%])中,44%(92 名)表现出对任何最近奥密克戎变体感染的认识,而 56%(118 名)报告对其感染状态不知情。在那些不知情的人中,有 10%(118 名中的 12 名)报告有任何症状,他们将这些症状归因于普通感冒或其他非 SARS-CoV-2 感染。在考虑了人口统计学和临床特征的多变量分析中,医疗中心的卫生保健员工比非员工更有可能意识到自己最近的奥密克戎变体感染(调整后的优势比,2.46;95%CI,1.30-4.65)。

结论和相关性

这项研究的结果表明,超过一半的最近感染奥密克戎变体的成年人不知道自己的感染状态,而卫生保健员工的知晓率高于非员工,但总体仍然较低。不知晓可能是与社区内人际快速传播密切相关的一个高度普遍的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/058243f9af3f/jamanetwopen-e2227241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/2a3493c94db5/jamanetwopen-e2227241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/529c8e7ccba3/jamanetwopen-e2227241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/058243f9af3f/jamanetwopen-e2227241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/2a3493c94db5/jamanetwopen-e2227241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/529c8e7ccba3/jamanetwopen-e2227241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/9386542/058243f9af3f/jamanetwopen-e2227241-g003.jpg

相似文献

1
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.奥密克戎变异株感染的知晓情况在近期新冠血清阳性的成年人中。
JAMA Netw Open. 2022 Aug 1;5(8):e2227241. doi: 10.1001/jamanetworkopen.2022.27241.
2
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
3
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.与以色列接种疫苗的医护人员免受 SARS-CoV-2 奥密克戎变异株感染和疾病相关的因素。
JAMA Netw Open. 2023 May 1;6(5):e2314757. doi: 10.1001/jamanetworkopen.2023.14757.
4
Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.免疫功能正常成年人在德尔塔变异株与奥密克戎变异株流行期间的急性和后期 COVID-19 结局。
JAMA Netw Open. 2023 Feb 1;6(2):e231181. doi: 10.1001/jamanetworkopen.2023.1181.
5
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
6
Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.德尔塔和奥密克戎变异株流行期间危重症成人 COVID-19 感染的临床特征和结局比较:单中心回顾性队列研究。
BMJ Open Respir Res. 2023 Feb;10(1). doi: 10.1136/bmjresp-2022-001274.
7
Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China.急性感染 SARS-CoV-2 奥密克戎变异株(B.1.1.529)的病毒和抗体动态:来自中国深圳的前瞻性队列研究。
Lancet Microbe. 2023 Aug;4(8):e632-e641. doi: 10.1016/S2666-5247(23)00139-8. Epub 2023 Jul 14.
8
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
9
Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.2020 年和 2021 年加拿大成年人中 SARS-CoV-2 血清阳性率在第一波和第二波疫情期间的评估。
JAMA Netw Open. 2022 Feb 1;5(2):e2146798. doi: 10.1001/jamanetworkopen.2021.46798.
10
Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada.加拿大儿童中与 SARS-CoV-2 变异株相关症状的比较。
JAMA Netw Open. 2023 Mar 1;6(3):e232328. doi: 10.1001/jamanetworkopen.2023.2328.

引用本文的文献

1
Comparison of six COVID-19 serology assays for detection of antibodies from patients infected with ancestral and a spectrum of SARS-CoV-2 variants.六种用于检测感染原始毒株和一系列新冠病毒变异株患者抗体的新冠病毒血清学检测方法的比较
Access Microbiol. 2025 Jul 7;7(7). doi: 10.1099/acmi.0.000974.v3. eCollection 2025.
2
Impact of Cancer Subtype and Cancer Therapy Exposures on SARS-CoV-2 Outcomes in the Omicron and Subvariant Era.癌症亚型和癌症治疗暴露对奥密克戎及其亚型流行时代严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染结局的影响
Cancer Med. 2025 Jul;14(14):e71082. doi: 10.1002/cam4.71082.
3
Sex differences in adenosine deaminase activity associate with disparities in SARS-CoV-2 innate immunity.

本文引用的文献

1
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.SARS-CoV-2 感染后抗核衣壳抗体在随机、安慰剂对照的 mRNA-1273 COVID-19 疫苗疗效临床试验的盲法阶段。
Ann Intern Med. 2022 Sep;175(9):1258-1265. doi: 10.7326/M22-1300. Epub 2022 Jul 5.
2
Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose.在以色列奥密克戎浪潮期间住院的严重 2019 冠状病毒病患者:第四剂疫苗的益处。
Clin Infect Dis. 2023 Feb 8;76(3):e234-e239. doi: 10.1093/cid/ciac501.
3
腺苷脱氨酶活性的性别差异与新冠病毒固有免疫的差异相关。
iScience. 2025 Apr 14;28(5):112418. doi: 10.1016/j.isci.2025.112418. eCollection 2025 May 16.
4
Proportions of US Blood Donors With Serological Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Who Reported Survey-Based Diagnosed Infections During July 2020-December 2022.2020年7月至2022年12月期间报告基于调查诊断感染的严重急性呼吸综合征冠状病毒2感染血清学证据的美国献血者比例。
Open Forum Infect Dis. 2025 Apr 10;12(5):ofaf210. doi: 10.1093/ofid/ofaf210. eCollection 2025 May.
5
Opportunities and Challenges in Using Electronic Health Record Systems to Study Postacute Sequelae of SARS-CoV-2 Infection: Insights From the NIH RECOVER Initiative.利用电子健康记录系统研究新冠病毒感染后急性后遗症的机遇与挑战:来自美国国立卫生研究院RECOVER计划的见解
J Med Internet Res. 2025 Mar 5;27:e59217. doi: 10.2196/59217.
6
The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变异株导致一所公立大学环境中的血清阳性率普遍上升。
PLOS Glob Public Health. 2025 Jan 3;5(1):e0003893. doi: 10.1371/journal.pgph.0003893. eCollection 2025.
7
Three-year Seroprevalence of SARS-CoV-2 Nucleocapsid Protein Antibody Among Children, Parental Awareness, and Contributors of Infection: A Single-school Cohort Study in Chiba, Japan.日本千叶单校队列研究:儿童中SARS-CoV-2核衣壳蛋白抗体的三年血清流行率、家长认知及感染因素
J Epidemiol. 2025 Jun 5;35(6):278-286. doi: 10.2188/jea.JE20240284. Epub 2025 Feb 28.
8
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination.感染或接种疫苗后感染严重急性呼吸综合征冠状病毒 2 的风险。
J Infect Dis. 2024 Sep 23;230(3):e584-e590. doi: 10.1093/infdis/jiae130.
9
Screening Strategies to Reduce COVID-19 Mortality in Nursing Homes.养老院降低 COVID-19 死亡率的筛查策略。
JAMA Health Forum. 2024 Apr 5;5(4):e240688. doi: 10.1001/jamahealthforum.2024.0688.
10
Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses.同时接种新冠疫苗和流感疫苗可增强刺突蛋白特异性抗体反应。
Open Forum Infect Dis. 2024 Mar 13;11(4):ofae144. doi: 10.1093/ofid/ofae144. eCollection 2024 Apr.
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis.
与学术医疗中心医护人员对 BNT162b2 COVID-19 疫苗的抗体反应差异相关的人口统计学和临床特征:一项纵向队列分析。
BMJ Open. 2022 May 24;12(5):e059994. doi: 10.1136/bmjopen-2021-059994.
4
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study.2021年12月至2022年1月法国出现症状性感染新冠病毒奥密克戎和德尔塔变异株后的严重住院事件:一项基于人群的回顾性配对队列研究。
EClinicalMedicine. 2022 Jun;48:101455. doi: 10.1016/j.eclinm.2022.101455. Epub 2022 May 20.
5
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.家庭环境中 SARS-CoV-2 变异株的二次感染率及其与疫苗接种状态的关系:一项更新的系统评价和荟萃分析。
JAMA Netw Open. 2022 Apr 1;5(4):e229317. doi: 10.1001/jamanetworkopen.2022.9317.
6
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
7
High Asymptomatic Carriage With the Omicron Variant in South Africa.南非奥密克戎变异株高无症状携带率。
Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.
8
Scaling SARS-CoV-2 wastewater concentrations to population estimates of infection.将 SARS-CoV-2 污水浓度转化为感染人群估计数。
Sci Rep. 2022 Mar 3;12(1):3487. doi: 10.1038/s41598-022-07523-7.
9
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022.SARS-CoV-2 B.1.1.529 (Omicron) 变异株在美四个州家庭内传播:2021 年 11 月至 2022 年 2 月
MMWR Morb Mortal Wkly Rep. 2022 Mar 4;71(9):341-346. doi: 10.15585/mmwr.mm7109e1.
10
Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.2021 年韩国发生的 SARS-CoV-2 奥密克戎变异株社区传播。
Emerg Infect Dis. 2022 Apr;28(4):898-900. doi: 10.3201/eid2804.220006. Epub 2022 Feb 16.